Trian Fund Management, L.P. 13F holdings and portfolio analysis
Sign in to clone a new branch from the selected plan, then continue optimizing in the new branch.
Baseline
Analysis messagesPre-generated Q&A about this fund. Use as reference context for your own analysis.
Directly following the baseline means accepting a highly concentrated six-name portfolio. In the strategy artifact, top five holdings are 99.99% and the top two alone are 73.91% through JHG at 40.63% and GE at 33.28%. Sector exposure is also narrow, with 42.72% Financials, 39.77% Industrials, and 17.51% Health Care. The backtest still generated 7.74% annualized return and 104.72% total return, but investors took a -33.02% max drawdown and negative -1.05 alpha versus SPY.
Three recent periods summarize the trade-off well. 2024-03-31 was the weakest, with -8.56% optimized return versus 2.31% for SPY, a -10.87% excess return, showing how painful concentration can be in the wrong quarter. 2023-09-30 was one of the best, with 15.47% return versus 10.11% for SPY and 5.37% excess return, but turnover was high at 54.64. More recently, 2025-03-31 returned 9.77% versus 9.22% for SPY and 2025-06-30 returned 5.15% versus 4.2%, showing the baseline can still keep up when its core holdings work.
A user should inspect concentration, implementation lag, and the worst drawdown path next. The baseline artifact flags 99.99% in the top five, 272 trades, and 1.4906 total estimated cost, while risk notes explicitly warn that filing-delay replication may reduce real-world results. It is also worth checking turnover spikes such as 63.15 on 2024-06-30 and 54.64 on 2023-09-30, because those periods likely changed exposure meaningfully. If those concentration and lag risks are not acceptable, the baseline probably is not the right choice despite its lower 0.69 beta.